BioPharma Resources

Drug Trial Radar · NCT06641414

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 490 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

490

Planned (sponsor's estimate)

Start

Jan 22, 2025

Primary completion

Jun 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Ascentage Pharma Group Inc.Industry
Sponsor type
Industry
First posted
Oct 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of lisaftoclax (APG-2575) combined with azacitidine (AZA) vs. placebo combined with azacitidine in newly diagnosed patients with HR-MDS.

Conditions

  • Higher-risk Myelodysplastic Syndrome

Interventions

  • Lisaftoclax (APG-2575)Drug

    QD, oral administration.

  • Azacitidine InjectionDrug

    QD, hypodermic or intravenous injection.

  • PlaceboOther

    QD, oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival(OS)Time frame: Up to 5 years

Locations

155 sites in 18 countries. Site status is shown where the registry gives one.

  • Ascentage Investigative Site

    Birmingham, Alabama · Not yet recruiting

  • Ascentage Investigative Site

    Phoenix, Arizona · Recruiting

  • Ascentage Investigative Site

    Los Angeles, California · Recruiting

  • Ascentage Investigative Site

    Sacramento, California · Recruiting

  • Ascentage Investigative Site

    San Diego, California · Recruiting

  • Ascentage Investigative Site

    Aurora, Colorado · Recruiting

  • Ascentage Investigative Site

    Jacksonville, Florida · Recruiting

  • Ascentage Investigative Site

    Chicago, Illinois · Recruiting

  • Ascentage Investigative Site

    Indianapolis, Indiana · Recruiting

  • Ascentage

    Iowa City, Iowa · Not yet recruiting

  • Ascentage Investigative Site

    Louisville, Kentucky · Recruiting

  • Ascentage Investigative Site

    Baltimore, Maryland · Recruiting

  • Ascentage Investigative Site

    Minneapolis, Minnesota · Recruiting

  • Ascentage Investigative Site

    Rochester, Minnesota · Recruiting

  • Ascentage Investigative Site

    St Louis, Missouri · Recruiting

  • Ascentage Investigative Site

    Lincoln, Nebraska · Recruiting

  • Ascentage Investigative Site

    Hackensack, New Jersey · Recruiting

  • Ascentage Investigative Site

    New York, New York · Recruiting

  • Ascentage Investigative Site

    Rochester, New York · Recruiting

  • Ascentage Investigative Site

    The Bronx, New York · Recruiting

  • Ascentage Investigative Site

    Charlotte, North Carolina · Recruiting

  • Ascentage Investigative Site

    Durham, North Carolina · Recruiting

  • Ascentage Investigative Site

    Winston-Salem, North Carolina · Recruiting

  • Ascentage Investigative Site

    Cleveland, Ohio · Recruiting

  • Ascentage Investigative Site

    Columbus, Ohio · Recruiting

  • Ascentage Investigative Site

    Eugene, Oregon · Recruiting

  • Ascentage Investigative Site

    Pittsburgh, Pennsylvania · Recruiting

  • Ascentage Investigative Site

    Providence, Rhode Island · Not yet recruiting

  • Ascentage Investigative Site

    Austin, Texas · Recruiting

  • Ascentage Investigative Site

    Houston, Texas · Recruiting

  • Ascentage Investigative Site

    Tyler, Texas · Recruiting

  • Ascentage Investigative Site

    Charlottesville, Virginia · Recruiting

  • Ascentage Investigative Site

    Manassas, Virginia · Recruiting

  • Ascentage Investigative Site

    Norfolk, Virginia · Recruiting

  • Ascentage Investigative Site

    Edmonds, Washington · Recruiting

  • Ascentage Investigative Site

    Issaquah, Washington · Recruiting

  • Ascentage Investigative Site

    Seattle, Washington · Recruiting

  • Ascentage Investigative Site

    Seattle, Washington · Recruiting

  • Ascentage Investigative Site

    Milwaukee, Wisconsin · Recruiting

  • Ascentage Investigative Site

    Waukesha, Wisconsin · Recruiting

Showing 40 of 155 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.